<?xml version="1.0" encoding="UTF-8"?>
<p>Despite advances in drug development, there are no antivirals available for the treatment of these rapidly spreading arboviruses. Current treatment available is primarily palliative, and solely serves to alleviate patientsâ€™ symptoms without any specific antiviral activity. Although the approval of some vaccines have been obtained for use in certain countries or are still undergoing development or clinical trials, it is still essential to develop treatments for people who are unable to receive the vaccine, and to care for unvaccinated infected patients [
 <xref rid="B19-molecules-25-02796" ref-type="bibr">19</xref>]. Therefore, there is a desperate need for the discovery and development of potent and effective antivirals against arboviruses to reduce the infection burden which impacts millions across the globe.
</p>
